JINAN,China,Sept. 19,2024-- This is a report from theShandong Office of Hong Kong Business Daily. In this rapidly changing era,Jinan not only preserves a thousand years of historical heritage and rich
Sep 20, 2024
VISTA,Calif.,Sept. 19,2024-- NUZEE,INC.,("NUZEE"or the "Company") (NASDAQ：NUZE) a Company with a heritage in specialty coffee and an emerging business in broader consumer food and
Sep 20, 2024
BEIJING,Sept. 19,2024-- By deepening reform comprehensively and expanding the level of opening-up,China has achieved historic transformations in many areas,contributing wisdom and strength to building
Sep 20, 2024
HEFEI,China,Sept. 19,2024-- The 2024 World Manufacturing Conference will take place from September 20 to 23,2024,inHefei,Anhui Province. A total of 31 well-known companies from 11 countries,including
Sep 20, 2024
Shang Haifeng from Huawei Cloud: Building a Resilient,Intelligent Hybrid Cloud and Taking an Intelligence Leap
Sep 20, 2024
NEW YORK and MIAMI and BUENOS AIRES,Argentina,Sept. 20,2024-- Bresh has partnered with Carroll Street Capital to launch Bresh Global,an international media and branded live events platform. Bresh Gl
Sep 20, 2024
Industry leaders to discuss AI in healthcare,cell and gene therapy,market access and more at premier life sciences event
Sep 19, 2024
SINGAPORE,Sept. 18,2024--Digital travel platform Agoda has joined forces with the Tourism Promotions Board (TPB) Philippines in an exciting new partnership designed to showcase the Philippines as a
Sep 19, 2024
Boomi,Microsoft,MIT CISR,PwC,and Tech Mahindra to keynote at the world\'s largest Industrial AI conference in Orlando,14-18 October 2024
Sep 19, 2024
MONTERREY,Mexico,Sept. 18,2024--Hoymiles,a world-leading provider of PV & energy storage solutions,officially inaugurated its first overseas manufacturing facility in Monterrey,marking a significa
Sep 19, 2024
New data shows U.S. adults prioritize price,quality,and style options when buying clothes LOS ANGELES,Sept. 18,2024-- When we look our best,we feel our best,according to recent research conducted on
Sep 19, 2024
Updated results with longer follow-up reveal confirmed ORR of 68% and median PFS of 14.2 months in patients with CLDN18.2 high or medium expression,known PD-L1 CPS (n=66).
Sep 19, 2024
Voice Of Zimbabwe: Your Source for Tech, AI, Aerospace, Biotech News
© Voice Of Zimbabwe Privacy Policy Contact us
